About Serendex Pharmaceuticals
Serendex Pharmaceuticals is a Healthcare company based in Copenhagen (Denmark) founded in 2008, and was acquired by Savara Pharma in July 2016. Pharmaceutical drug development company focusing on respiratory conditions. The company has 1 employees. The company was acqui-hired. Its focus areas include Life Sciences, Pulmonology, Drugs and Diversified. Its legal entity is Serenova A/S.
Company details
Serendex Pharmaceuticals was founded in 2008 in Copenhagen, Denmark. Focus is placed on pharmaceutical drug development for pulmonary diseases and respiratory conditions. The pipeline includes GM-CSF targeted at pulmonary alveolar proteinosis in phase 2b3, acute respiratory distress syndrome in phase 2b, and bronchiectasis in phase 2a, though the bronchiectasis trial is currently on hold. Operations center on advancing clinical trials in this sector.
- Headquarters Copenhagen, Denmark
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Website serendex.com
- Social LinkedIn
- Acquired by Savara Pharma (Jul 2016)
- Legal Name Serenova A/S
- Investors
- Employee Count1
- Acquired bySavara Pharma
(Jul 2016)
Investors in Serendex Pharmaceuticals
Serendex Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Savara Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | 2008 | savarapharma.com | Austin, United States |
Investor details for Serendex Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Serendex Pharmaceuticals
2 dated milestones of Serendex Pharmaceuticals across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Serendex Pharmaceuticals is founded.
- Exit Acquired by Savara Pharma.
Web traffic of Serendex Pharmaceuticals
The website of Serendex Pharmaceuticals (serendex.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 59.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Serendex Pharmaceuticals
Serendex Pharmaceuticals was founded in 2008.
Serendex Pharmaceuticals is headquartered in Copenhagen, Denmark.
Serendex Pharmaceuticals has 1 employees.
Serendex Pharmaceuticals was founded in 2008 in Copenhagen, Denmark. Focus is placed on pharmaceutical drug development for pulmonary diseases and respiratory conditions. The pipeline includes GM-CSF targeted at pulmonary alveolar proteinosis in phase 2b3, acute respiratory distress syndrome in phase 2b, and bronchiectasis in phase 2a, though the bronchiectasis trial is currently on hold. Operations center on advancing clinical trials in this sector.
Serendex Pharmaceuticals has 1 investor. Key investors include Savara Pharma.
Serendex Pharmaceuticals operates through Serenova A/S.
Yes. Serendex Pharmaceuticals was acquired by Savara Pharma in July 2016.